A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis

NCT00703573 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

209

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: S-777469 400 mg
DRUG: S-777469 800 mg
DRUG: Placebo

Sponsor

Shionogi